Eric Lefkofsky’s Breast Cancer Treatment through Data Analysis

Cancer is the leading chronic killer disease in the world today. Scientists and medics have buried their heads in extensive research in pursuit of discovering its cure to no avail. Therefore, medical practitioners have opted to take up the prevention angle to reduce its increased dominance rather than curing. Eric Lefkoskyf as well has joined in the battle against cancer.Eric Lefkofsky graduated from Michigan University. He stands as both a co-founder and CEO of Tempus, a technological company that has developed an operating system to fight cancer. The Initiative was founded in 2015, but its effect in the health market was felt a year later 2016. He has also founded Lightbank that invests in disruptive technologies, co-founder and Chairman of Groupon, Uptake Technologies, Mediaocean, Echo Global Logistics and InnerWorking. Besides, he has established the Lefkofsky Family Foundation, a charitable organization.

Eric Lefkofsky through Tempus works to give University of Chicago doctors’ data as a means to help treat breast cancer patients better. They in collaboration provide molecular sequencing and analysis to cancer specialists to create personalized treatment plans for cancer patients. Through the leadership of Eric, Tempus has offered to analyze data of over 1000 breast cancer patients as a means of helping medics and researchers unearth patterns that can forecast how patients will respond to administered treatment.

Tempus critically analyzed the health sector and realized that despite breast cancer being among the most common of cancers, there is a little reach to data about the millions of patients on record to have been afflicted with the disease. It has been a major setback to physicians in developing a specialized treatment to patients. Therefore, this has formed the basis for the partnership between the two institutions.Tempus is renowned for its mechanization and has considerably used machine learning and genomic sequencing to assist doctors to make more informed, personalized decisions on treatment. It also partners with other facilities all over America to use data in the fight against cancer. Its goal is to oversee the utilization of this data over time and help lead to better treatment and improved patient results.

Leave a Reply

Your email address will not be published. Required fields are marked *